365 related articles for article (PubMed ID: 22200056)
21. Mesoporous Silica Platforms with Potential Applications in Release and Adsorption of Active Agents.
Chircov C; Spoială A; Păun C; Crăciun L; Ficai D; Ficai A; Andronescu E; Turculeƫ ȘC
Molecules; 2020 Aug; 25(17):. PubMed ID: 32825791
[TBL] [Abstract][Full Text] [Related]
22. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules.
Lai CY; Trewyn BG; Jeftinija DM; Jeftinija K; Xu S; Jeftinija S; Lin VS
J Am Chem Soc; 2003 Apr; 125(15):4451-9. PubMed ID: 12683815
[TBL] [Abstract][Full Text] [Related]
23. Sub-150 nm mesoporous silica nanoparticles with tunable pore sizes and well-ordered mesostructure for protein encapsulation.
Gu J; Huang K; Zhu X; Li Y; Wei J; Zhao W; Liu C; Shi J
J Colloid Interface Sci; 2013 Oct; 407():236-42. PubMed ID: 23866201
[TBL] [Abstract][Full Text] [Related]
24. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
[TBL] [Abstract][Full Text] [Related]
25. Using shell-tunable mesoporous Fe3O4@HMS and magnetic separation to remove DDT from aqueous media.
Tian H; Li J; Shen Q; Wang H; Hao Z; Zou L; Hu Q
J Hazard Mater; 2009 Nov; 171(1-3):459-64. PubMed ID: 19586720
[TBL] [Abstract][Full Text] [Related]
26. Luminescence functionalization of mesoporous silica with different morphologies and applications as drug delivery systems.
Yang P; Quan Z; Lu L; Huang S; Lin J
Biomaterials; 2008 Feb; 29(6):692-702. PubMed ID: 17996294
[TBL] [Abstract][Full Text] [Related]
27. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017
[TBL] [Abstract][Full Text] [Related]
28. A mesoporous silica nanoparticle with charge-convertible pore walls for efficient intracellular protein delivery.
Park HS; Kim CW; Lee HJ; Choi JH; Lee SG; Yun YP; Kwon IC; Lee SJ; Jeong SY; Lee SC
Nanotechnology; 2010 Jun; 21(22):225101. PubMed ID: 20453291
[TBL] [Abstract][Full Text] [Related]
29. Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release.
Zheng Q; Lin T; Wu H; Guo L; Ye P; Hao Y; Guo Q; Jiang J; Fu F; Chen G
Int J Pharm; 2014 Mar; 463(1):22-6. PubMed ID: 24393764
[TBL] [Abstract][Full Text] [Related]
30. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity.
Lin YS; Haynes CL
J Am Chem Soc; 2010 Apr; 132(13):4834-42. PubMed ID: 20230032
[TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evaluation of paclitaxel-loaded mesoporous silica nanoparticles with three pore sizes.
Jia L; Shen J; Li Z; Zhang D; Zhang Q; Liu G; Zheng D; Tian X
Int J Pharm; 2013 Mar; 445(1-2):12-9. PubMed ID: 23384728
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, amino-functionalization of mesoporous silica and its adsorption of Cr(VI).
Li J; Miao X; Hao Y; Zhao J; Sun X; Wang L
J Colloid Interface Sci; 2008 Feb; 318(2):309-14. PubMed ID: 18036539
[TBL] [Abstract][Full Text] [Related]
33. Effective controlled release of captopril by silylation of mesoporous MCM-41.
Qu F; Zhu G; Huang S; Li S; Qiu S
Chemphyschem; 2006 Feb; 7(2):400-6. PubMed ID: 16411260
[TBL] [Abstract][Full Text] [Related]
34. Monodispersed mesoporous silica nanoparticles with very large pores for enhanced adsorption and release of DNA.
Gao F; Botella P; Corma A; Blesa J; Dong L
J Phys Chem B; 2009 Feb; 113(6):1796-804. PubMed ID: 19152258
[TBL] [Abstract][Full Text] [Related]
35. Variation of the crystal growth of mesoporous silica nanoparticles and the evaluation to ibuprofen loading and release.
Kamarudin NH; Jalil AA; Triwahyono S; Artika V; Salleh NF; Karim AH; Jaafar NF; Sazegar MR; Mukti RR; Hameed BH; Johari A
J Colloid Interface Sci; 2014 May; 421():6-13. PubMed ID: 24594025
[TBL] [Abstract][Full Text] [Related]
36. Intracellular degradation of multilabeled poly(ethylene imine)-mesoporous silica-silica nanoparticles: implications for drug release.
Bergman L; Kankaanpää P; Tiitta S; Duchanoy A; Li L; Heino J; Lindén M
Mol Pharm; 2013 May; 10(5):1795-803. PubMed ID: 23510188
[TBL] [Abstract][Full Text] [Related]
37. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects.
Zhao Y; Sun X; Zhang G; Trewyn BG; Slowing II; Lin VS
ACS Nano; 2011 Feb; 5(2):1366-75. PubMed ID: 21294526
[TBL] [Abstract][Full Text] [Related]
38. A Biodegradation Study of SBA-15 Microparticles in Simulated Body Fluid and in Vivo.
Choi Y; Lee JE; Lee JH; Jeong JH; Kim J
Langmuir; 2015 Jun; 31(23):6457-62. PubMed ID: 26013363
[TBL] [Abstract][Full Text] [Related]
39. Nanoparticles of mesoporous SO3H-functionalized Si-MCM-41 with superior proton conductivity.
Marschall R; Bannat I; Feldhoff A; Wang L; Lu GQ; Wark M
Small; 2009 Apr; 5(7):854-9. PubMed ID: 19226596
[TBL] [Abstract][Full Text] [Related]
40. Enantioselectively controlled release of chiral drug (metoprolol) using chiral mesoporous silica materials.
Guo Z; Du Y; Liu X; Ng SC; Chen Y; Yang Y
Nanotechnology; 2010 Apr; 21(16):165103. PubMed ID: 20351409
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
